FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
DAVIS JAMES L

(Last) (First) (Middle)
6446 FLYING CLOUD DR

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ProUroCare Medical Inc. [ PUMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/12/2011
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.00001 par value 94,964 I Held by "Davis & Associates 401K PSP"(2)
Common Stock, $0.00001 par value 57,482 I Held by "Davis & Associates Inc."(2)
Common stock, $0.0001 par value 04/12/2011 A(6) 6,667 A $0.525 2,245,687 D
Common Stock, $0.00001 par value 04/21/2011 A(5) 113,333(5) A $0.54 2,359,020 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants $5 (1) 12/27/2012 Common stock, $0.00001 par value 5,800 5,800 D
Warrants $5 (1) 12/27/2012 Common stock, $0.00001 par value 6,050 6,050 I Held by "Davis & Associates Inc. 401K PSP"(2)
Warrants $5 (1) 12/27/2012 Common stock, $0.00001 par value 700 700 I Held by "Davis & Associates Inc."(2)
Warrants $1.5 (1) 04/03/2013 Common stock, $0.00001 par value 25,000 25,000 D
Warrants $0.5 (1) 12/31/2012 Common stock, $0.00001 par value 30,000 30,000 D
Warrants $0.7 (1) 12/31/2012 Common stock, $0.00001 par value 30,000 30,000 D
Warrants $0.7 (1) 12/31/2012 Common stock, $0.00001 par value 10,000 10,000 I Held by "Davis & Associates Inc. 401K PSP"(2)
Warrants $0.7 (1) 12/31/2012 Common stock, $0.00001 par value 5,000 5,000 I Held by "Davis & Associates Inc."(2)
Warrants $1 (1) 12/31/2012 Common stock, $0.00001 par value 30,000 30,000 D
Warrants $1.5 (1) 09/25/2013 Common stock, $0.00001 par value 100,000 100,000 D
Warrants $2 10/31/2009 10/31/2013 Common Stock, $0.00001 par value 16,667 16,667 D
Warrants(3) $1.3 (1) 01/07/2014 Common Stock, $0.00001 par value 195,000 195,000 D
Options $2.41 (4) 03/01/2017 Common stock, $0.00001 par value 10,374 10,374 D
Warrant $1.3 (1) 07/12/2013 Common stock, $0.00001 par value 100,000 100,000 D
Warrant $1.3 (1) 07/12/2013 Common stock, $0.00001 par value 20,000 20,000 I Held by "Davis & Associates Inc. 401(k) PSP"(2)
Warrant $1.3 (1) 07/12/2013 Common stock, $0.00001 par value 20,000 20,000 I Held by "Davis & Associates Inc."(2)
Warrant(3) $1.3 (1) 01/07/2014 Common stock, $0.00001 par value 127,923 127,923 D
Warrants $1.3 (1) 08/02/2013 Common stock, $0.0001 par value 286,923 286,923 D
Warrants(3) $1.3 (1) 01/07/2014 Common stock, $0.00001 par value 54,964 54,964 I Held by "Davis & Associates Inc. 401K PSP"(2)
Warrants $1.3 (1) 08/02/2013 Common stock, $0.0001 par value 20,000 20,000 I Held by Davis & Associates, Inc. 401(k) PSP(2)
Warrants(3) $1.3 (1) 01/07/2014 Common stock, $0.00001 par value 17,482 17,482 I Held by "Davis & Associates Inc."(2)
Warrants $1.3 (1) 08/02/2013 Common stock, $0.0001 par value 20,000 20,000 I Held by Davis & Associates, Inc.(2)
Options $1.72 (1) 08/10/2017 Common stock, $0.00001 par value 14,535 14,535 D
Warrants(3) $1.3 (1) 01/07/2014 Common stock, $0.00001 par value 50,000 50,000 D
Explanation of Responses:
1. Currently exercisable
2. Reporting person is the Sole owner of Davis & Associates Inc. and has sole voting power.
3. The warrants were purchased as part of as a Unit at a price of $1.00 per unit. Each unit consisted of one share of $0.00001 par value common stock and one redeemable five-year warrant to purchase one share of common stock at $1.30 per share. The warrants became exercisable and separately transferable from the shares of common stock on February 6, 2009.
4. Options vest as to 433 shares per month for 23 months beginning April 1, 2010 and as to 415 shares on March 1, 2012.
5. On April 21, 2011, the issuer entered into a loan guarantee agreement pursuant to which the reporting person was issued 83,333 shares of common stock as compensation for guaranteeing $900,000 of the issuer's bank debt from March 28, 2011 through September 28, 2011. In addition, the issuer issued 30,000 shares of common stock as compensation earned pursuant to a June 28, 2010 loan guarantee agreement for the period from December 28, 2010 through March 28, 2011. All 113,333 shares were approved by the issuer's Board of Directors and are exempt under Section 16b-3(d).
6. Shares issued in lieu of cash for directors' fees as approved by the issuer's Board of Directors, which are exempt under Section 16b-3(d).
Remarks:
Richard B. Thon by power of attorney 04/21/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.